ADC Therapeutics (ADCT) Receivables (2021 - 2026)
ADC Therapeutics' Receivables was $28.04 million in Q2 2026, up 7.1% from $26.18 million a year earlier but down 9.7% from the prior quarter.
Powered by 
Analysis
ADC Therapeutics (ADCT) Receivables (2021 - 2026) Analysis & Trends
At the end of FY2025, Receivables at ADC Therapeutics came in at $29.12 million, up 43.3% from FY2024.
- Receivables shows a four-year compound annual growth rate of -0.9% (FY2021 to FY2025).
- In earlier years, Receivables was $20.32 million in FY2024 (-19.3%), $25.18 million in FY2023 (-65.5%), $72.97 million in FY2022 (+141.5%) and $30.22 million in FY2021.
- Quarterly Receivables has moved between $15.9 million (Q3 2021) and $72.97 million (Q4 2022) over five years.
- Compared with a year earlier, Receivables was higher in five of the last eight quarters, with growth averaging 11.1%.
- The best year-over-year quarter for Receivables over five years was Q2 2022 (growth of 903.5%); the worst was Q4 2023 (a decline of 65.5%).
- Per Business Quant data, ADCT's Receivables in the three quarters before Q2 2026 was $31.05 million (Q1 2026), $29.12 million (Q4 2025) and $22.92 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,132.46 Bn | 1,101.04 Bn | 19.71 Bn | 23.48 Bn |
| 2 | Johnson & Johnson | 614.45 Bn | 532.98 Bn | 17.26 Bn | 19.05 Bn |
| 3 | AbbVie | 503.76 Bn | 476.87 Bn | 12.70 Bn | 13.82 Bn |
| 4 | Merck | 367.67 Bn | 322.05 Bn | 12.21 Bn | 12.56 Bn |
| 5 | Novartis Ag | 298.09 Bn | 262.08 Bn | 11.24 Bn | 9.64 Bn |
| 6 | Astrazeneca | 261.81 Bn | 235.50 Bn | 12.86 Bn | 15.68 Bn |
| 7 | Amgen | 236.49 Bn | 191.89 Bn | 7.24 Bn | 10.23 Bn |
| 8 | Gilead Sciences | 191.25 Bn | 165.45 Bn | 6.22 Bn | 5.06 Bn |
| 9 | Pfizer | 170.18 Bn | 116.83 Bn | 10.94 Bn | 12.49 Bn |
| 10 | ADC Therapeutics | 226.32 Mn | -719.87 Mn | 16.90 Mn | 28.04 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 28.04 Mn |
| Mar 31, 2026 | 31.05 Mn |
| Dec 31, 2025 | 29.12 Mn |
| Sep 30, 2025 | 22.92 Mn |
| Jun 30, 2025 | 26.18 Mn |
| Mar 31, 2025 | 31.76 Mn |
| Dec 31, 2024 | 20.32 Mn |
| Sep 30, 2024 | 24.03 Mn |
| Jun 30, 2024 | 22.87 Mn |
| Mar 31, 2024 | 23.19 Mn |
| Dec 31, 2023 | 25.18 Mn |
| Sep 30, 2023 | 21.18 Mn |
| Jun 30, 2023 | 23.87 Mn |
| Mar 31, 2023 | 24.04 Mn |
| Dec 31, 2022 | 72.97 Mn |
| Sep 30, 2022 | 23.25 Mn |
| Jun 30, 2022 | 20.86 Mn |
| Mar 31, 2022 | 26.75 Mn |
| Dec 31, 2021 | 30.22 Mn |
| Sep 30, 2021 | 15.90 Mn |
API Access
ADC Therapeutics Receivables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=receivables&ticker=ADCT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "receivables", "ticker": "ADCT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=receivables&ticker=ADCT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();